After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Earlier, Yahoo Finance discussed this stock as it revealed Organon Announces HADLIMA™ (adalimumab-bwwd) Has Been Exclusively Selected by the US Department of Veterans Affairs (VA), Replacing HUMIRA on Its National Formulary.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
This NYSE-listed company operates within the Drug Manufacturers – General industry segment, falling under the Healthcare sector. The current market capitalization of Organon & Co. is $4.74B. A total of 3.29 million shares were traded on the day, compared to an average of 3.99M shares.
Insider trades can also provide insight into a stock’s future direction. During the recent three months, OGN has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 40 BUYs and 40 SELLs from insiders. Insiders purchased 223,528 shares during that period but sold 93,975.
Dividend
The income generated by dividends is an indication that a company is improving its financial position, which is why investors prefer companies paying dividends. Organon & Co. pays an annual dividend of $1.12, resulting in a dividend yield of 6.04%, and it has a price to earnings (P/E) ratio of 4.64. OGN’s most recent ex-dividend date was 2/23/2024 when it declared a $0.28 quarterly dividend that was paid in cash on 3/14/2024. Previously, the company paid the dividend on 12/14/2023 with an ex-dividend date of 11/10/2023. The OGN stock dividend was $0.28 per share in cash.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. According to analysts who have offered 12-month price targets for OGN in the last 3 months, the mean price target is $21.38 with high estimates of $28.00 and low estimates of $15.00. In terms of 52-week highs and lows, OGN has a high of $27.33 and a low of $10.84.
As of this writing, OGN has an earnings estimate of $1.07 per share for the current quarter. EPS was calculated based on a consensus of 6 estimates, with a high estimate of $1.19 per share and a lower estimate of $0.9. The company reported an EPS of $0.87 in the last quarter, which was -17.90% lower than expectations of $1.06.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. OGN’s latest balance sheet shows that the firm has $737.00M in Cash & Short Term Investments as of fiscal 2021. There were $9.13B in debt and $2.60B in liabilities at the time. Its Book Value Per Share was -$2.30, while its Total Shareholder’s Equity was -$1.51B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for OGN is Buy with a score of 3.43.
